BioCentury
ARTICLE | Clinical News

VioQuest preclinical data

January 28, 2008 8:00 AM UTC

In vitro VQD-002, a tricyclic nucleoside that inhibits Akt phosphorylation, reduced cancer cell survival with or without cisplatin. Also, the microRNA miR-214 activated the Akt pathway and induced ova...